Replies to post #141429 on PharmaCyte Biotech Inc (PMCB)

[livendi]

Pmcb and kw and cronies are absolute scumbags. To use a pancreatic cancer trial that never had a chance of approval to fleece people proves it. Nevermind kw and cronies past. Again those that deceive people to get their money will have to answer for it 1 day. Absolutely awful

[DragonBear]

Not that PMCB is even a real Biotech but if they were their old tech is worthless.

Mickey Mouse antiquated.

Galera Therapeutic...

Another thing to notice is the time required. They got their IND approved 2017. Started in 2018. Top line results 2020. Estimated completion for Phase 1-2 June 2022. A time interval of 5 yrs. A Phase 2b already approved, and expected to last to 2027. Another 6 yrs. That's already with solid positive results. Then it will be time for a Phase 3.

Now compare to PMCB...

Kenny spent years issuing PR pumps about how PMCB would start a Phase 2b. That it would be a "pivotal" trial. Where 6 months after starting preliminary results would come in, and Yippee off to Phase 3 one goes. With the SHs believing that would only take a few months to get market approval via "accelerated approval".

Strange how every biotech out there have Clinical Trials that last 5 yrs for Phase 1-2, and another 5 yrs for Phase 3. Even with outstanding results. But in Kenny's world a few months for each will do.

The result is after 7 yrs of Kenny PR pumps a frozen IND on Hold. And another 10 yrs to go...